184 related articles for article (PubMed ID: 11729210)
1. Light chain amyloidosis of the urinary bladder. A site restricted deposition of an externally produced immunoglobulin.
Livneh A; Shtrasburg S; Martin BM; Baniel J; Gal R; Pras M
J Clin Pathol; 2001 Dec; 54(12):920-3. PubMed ID: 11729210
[TBL] [Abstract][Full Text] [Related]
2. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
Olsen KE; Sandgren O; Sletten K; Westermark P
Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
[TBL] [Abstract][Full Text] [Related]
3. Primary localized amyloidosis of the bladder: an immunohistochemical study of a case.
Ehara H; Deguchi T; Yanagihara M; Yokota T; Uchino F; Kawada Y
J Urol; 1992 Feb; 147(2):458-60. PubMed ID: 1732619
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
[TBL] [Abstract][Full Text] [Related]
5. Identity of a peritoneal fluid immunoglobulin light chain and the amyloid fibril in primary amyloidosis.
Block PJ; Skinner M; Benson MD; Cohen AS
Arthritis Rheum; 1976; 19(4):755-9. PubMed ID: 821491
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin heavy-chain-associated amyloidosis.
Eulitz M; Weiss DT; Solomon A
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
Husby G; Sletten K; Blumenkrantz N; Danielsen L
Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
[TBL] [Abstract][Full Text] [Related]
8. Primary localized amyloidosis of the urinary bladder: a case series of 31 patients.
Tirzaman O; Wahner-Roedler DL; Malek RS; Sebo TJ; Li CY; Kyle RA
Mayo Clin Proc; 2000 Dec; 75(12):1264-8. PubMed ID: 11126834
[TBL] [Abstract][Full Text] [Related]
9. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
[TBL] [Abstract][Full Text] [Related]
10. The antisense approach in amyloid light chain amyloidosis: identification of monoclonal Ig and inhibition of its production by antisense oligonucleotides in in vitro and in vivo models.
Ohno S; Yoshimoto M; Honda S; Miyachi S; Ishida T; Itoh F; Endo T; Chiba S; Imai K
J Immunol; 2002 Oct; 169(7):4039-45. PubMed ID: 12244207
[TBL] [Abstract][Full Text] [Related]
11. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
[TBL] [Abstract][Full Text] [Related]
12. Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results.
Linke RP; Geisel O; Mann K
Biol Chem Hoppe Seyler; 1991 Sep; 372(9):835-43. PubMed ID: 1772596
[TBL] [Abstract][Full Text] [Related]
13. Primary amyloidosis of the bladder: a case report.
Tan SM; Tan PK; Yap WM
Ann Acad Med Singap; 1996 Jul; 25(4):612-3. PubMed ID: 8893942
[TBL] [Abstract][Full Text] [Related]
14. Tumour-like localized amyloid of the brain is derived from immunoglobulin light chain.
Eriksson L; Sletten K; Benson L; Westermark P
Scand J Immunol; 1993 Jun; 37(6):623-6. PubMed ID: 8316759
[TBL] [Abstract][Full Text] [Related]
15. The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.
Omtvedt LA; Husby G; Cornwell GG; Kyle RA; Sletten K
Scand J Immunol; 1997 May; 45(5):551-6. PubMed ID: 9160102
[TBL] [Abstract][Full Text] [Related]
16. Localized amyloidosis of the urinary tract: case series of nine patients.
Merrimen JL; Alkhudair WK; Gupta R
Urology; 2006 May; 67(5):904-9. PubMed ID: 16635518
[TBL] [Abstract][Full Text] [Related]
17. Primary bladder amyloidosis.
Kobayashi T; Roberts J; Levine J; Degrado J
Intern Med; 2014; 53(21):2511-3. PubMed ID: 25366012
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain.
Hoshii Y; Nanbara H; Cui D; Takahashi M; Ikeda E
Med Mol Morphol; 2012 Jun; 45(3):124-8. PubMed ID: 23001294
[TBL] [Abstract][Full Text] [Related]
19. Localized amyloidosis of the larynx: evidence for light chain composition.
Berg AM; Troxler RF; Grillone G; Kasznica J; Kane K; Cohen AS; Skinner M
Ann Otol Rhinol Laryngol; 1993 Nov; 102(11):884-9. PubMed ID: 8239352
[TBL] [Abstract][Full Text] [Related]
20. Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data.
Kaplan B; Martin BM; Livneh A; Pras M; Gallo GR
Am J Clin Pathol; 2004 Jun; 121(6):794-800. PubMed ID: 15198349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
